FibroBiologics Secures U.S. Patent for Disc Regeneration
Houston, Texas, September 1, 2026 FibroBiologics, Inc. has announced the issuance of a new U.S. patent covering a potential...
degenerative disc disease
Advertisement
IceCure Advances Breast Cancer Cryoablation Study
Caesarea, Israel, August 20, 2026 IceCure Medical has announced an important clinical development for its minimally invasive ProSense® cryoablation...
FibroBiologics Gains Australian Patent for Disc Therapy
Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...
Mesoblast Completes Treatment in Phase 3 Low Back Pain Trial
New York, USA / Melbourne, Australia August 17, 2026: Mesoblast Limited has completed patient treatment in its pivotal Phase...
Sumitomo Pharma America Doses First Patient With DSP-3077
MARLBOROUGH, Mass., August 12, 2026 Sumitomo Pharma America, Inc. announced that the first patient has received treatment with DSP-3077...
Advertisements
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months
BURLINGTON, Mass., August 12, 2026 Bone Biologics Corporation announced that its rhNELL-1 protein has achieved a validated shelf life...
Helus Pharma Completes Enrollment in Phase 3 HLP003 Trial
NEW YORK and TORONTO, July 21, 2026 Helus Pharma has announced the successful completion of patient enrollment ahead of...
Synergy Spine Accelerates Cervical Disc Adoption Across the U.S.
LOUISVILLE, Colo., July 21, 2026 Synergy Spine Solutions has announced a major commercial milestone for its FDA-approved Synergy Disc®,...
Mesoblast Completes Enrollment in Low Back Pain Trial
NEW YORK and MELBOURNE, July 13-14, 2026 Mesoblast Limited announced that it has achieved its target of treating at...
SurGenTec Gains FDA Clearance for ION-L Spine System
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
Advertisement
